The Un-selfie4CMT Campaign!

by | Aug 19, 2014 | 2 comments

SelfieHNF introduces our latest initiative to reach millions of people worldwide and raise money for CMT research using Text2give.

The Un-selfie4CMT campaign is not about disability. It is about celebrating and sharing our passions for the activities we are blessed enough to enjoy. We want to encourage others to take a moment of reflection and gratitude for the activities their bodies allow them to do, whether it is playing with their young children, preparing a delicious meal, painting, swimming, running, gardening, dancing, weightlifting. These activities are gifts and should be recognized as so.

Charcot-Marie-Tooth (CMT) is only one of the many diseases that threaten and effect the passions we sometimes take for granted, and it is a disease that has been in the shadows for far too long. Even though the 2.6 million people suffering with CMT exceeds the 2.3 million people affected with Multiple Sclerosis (MS), there is much less awareness about our disease, and substantially less funding for research towards treatments and a cure.

We have the power to change this…let’s put social media to work and celebrate our individual passions with action.

Its quite simple:

1. Download and print the unselfie flyer at

2. Fill in what you are passionate about, take your unselfie

3. Upload your unselfie at

4. Please don’t wait, download your photo today 
at as HNF prepares for the launch of Un-selfie4CMT campaign on September 1st.

The Hereditary Neuropathy Foundation thanks Estela Lugo, the brains behind the Un-selfie4CMT Campaign. Estela was first introduced to HNF in 2009 when her physical trainer showed her a copy of a recent HNF Newsletter. Estela’s trainer was also the trainer for Allison Moore, the Founder and CEO of HNF, who shares with Estela the common struggle of living with CMT. Estela has been actively spreading awareness via social media, fundraising, and participating in local events. Let’s 
 so we can be 

Text CMT to 501501 to donate $10 and
then share your un-selfie on social
media! #UnSelfie4CMT

Learn more on this topic

Related Blog Posts

Double Your Donation

Corporate matching gift programs are charitable giving programs setup by corporations in which the company matches donations made by employees to eligible nonprofit organizations. For example, if a donor works for Bank of America and donates $100 to the Hereditary Neuropathy Foundation, Bank of America will double the donation by also writing a check for $100.

Taking Matters Into Your Own Hands

Do you have a rare form of CMT?

We were contacted recently from a patient with CMT2D who was looking for advice on how to make a difference. Our recommendations for all people with an ultra-rare form of CMT who want to get involved:

Now GRIN is Accessible in 141 Different Languages!

Now GRIN is Accessible in 141 Different Languages!

The Global Registry for Inherited Neuropathies (GRIN) has implemented Google Translate. Why did we choose Google? Because Google is leading the way in teaching computers how to interpret meaning, avoiding the traditional method of decoding language.

Accelerating Patient Access to Investigational Drugs in 2015

Accelerating Patient Access to Investigational Drugs in 2015

Currently the FDA is working to update the process for physicians applying for accelerated patient access to investigational drugs, while the drug or biological product is being tested in clinical trials. This will also be important for the CMT community as clinical trials for this disease are being launched.

Do You Have Charcot-Marie-Tooth Type 4 (CMT4)? – We Need Your Help

Autosomal recessive demyelinating CMT4 patients present with earlyonset and slowly progressing symptoms. These include progressive distally accentuated weakness and atrophy of muscles in the lower limbs. In addition, patients may have weakness and atrophy of hands, sensory loss and pes cavus (high-arched feet), and walking difficulties. Further information on CMT4 can be found at Orphanet.

Hot Off the Press – Potential Treatment for CMT1A

Two recent publications from Pharnext describe a novel synergistic combination of 3 drugs (baclofen, naltrexone and sorbitol) and its effect on CMT1A both in the lab and in a phase II clinical trial. These 3 drugs already approved but for unrelated conditions, are combined at new optimal lower doses and under a new formulation. This novel potential therapeutic is called PXT-3003.

Support CMT Therapeutic Alliance

HNF has entered into a joint venture – the CMT Therapeutic Alliance – with a unique non profit organization (BioPontis Alliance for Rare Diseases) that brings professional drug discovery capabilities to translate our research results into potential treatments.

Scientific Advisory Board Meeting

Scientific Advisory Board Meeting

On the 7th of November we convened our scientific advisory board meeting at the HNF offices in NY. We have written a detailed review that has been published and captures all of the discussion and make this freely available to the scientific community.

Join the conversation

Leave a Comment


  1. Mel H

    Which organization is the money going to?

    • courtney

      The money is going to research for Charcot-Marie-Tooth.


Submit a Comment

Your email address will not be published. Required fields are marked *


Join for notifications on events, campaigns, & news